IPCA Laboratories shares dropped 2.8% after Nomura and HSBC Research lowered their price targets due to revised revenue growth guidance and potential margin pressures. Despite recent profit gains, the stock is down 18.3% YTD with high trading volume.
Desco Infratech Wins ₹9.5 Cr Orders
TVS Motor Completes Killwatt Stake Deal
Ola Electric Rolls Out One‑Millionth Vehicle
Prime Focus Sees Big Investor Moves
Indian Shares Rebound on Trade & Rate Cut Hopes
US Markets Mixed Amid Debt & Tax Concerns
Rupee Stable Amid Oil Tensions, Fed Watch Looms
News that matters the most ⚡